Premature Peripheral Atherosclerosis

DeBakey ME , Crawford ES , Garrett HE , Cooley DA , Morris GC , Abbott JP . Occlusive disease of the lower extremities in patients 16 to 37 years of age. Ann Surg 1964; 159: 873–90.

Najafi H , Ostermiller WE , Ardekani RG Aortoiliac reconstruction in patients aged 32 to 45 years of age. Arch Surg 1970; 101: 780–4.

Pairolero PC , Joyce JW , Skinner CR , Hollier LH , Cherry KJ . Lower limb ischemia in young adults: prognostic implications. J Vasc Surg 1984; 1: 459–64.

Miani S , Mingazzini P , Biasi GM , Ruberti U. Occlusive disease in young patients. J Cardiovasc Surg (Torino) 1984; 25: 353–6.

Sise MJ , Shackford SR , Rowley WR , Pistone FJ . Claudication in young adults: a frequently delayed diagnosis. J Vasc Surg 1989; 10: 68–74.

Snyder BD , Ramirez-Lassepas M. Cerebral infarction in young adults. Long term prognosis. Stroke 1980; 11: 149–53.

Greenwood LH , Hallett JW Jr , Yrizarry JM , Robison JG , Brown SB . The angiographic evaluation of lower-extremity arterial disease in the young adult. Cardiovasc Intervent Radiol 1985; 8: 183–6.

McReady RA , Vincent AE , Schwartz RW , Hyde GL , Mattingly SS , Griffen WO . Atherosclerosis in the young: a virulent disease. Surgery 1984; 96: 863–8.

Nunn DB . Symptomatic peripheral atherosclerosis of patients under age 40. Am Surg 1973; 39: 224–8.

Bouhoutsos J , Martin P. The influence of age on prognosis after arterial surgery for atherosclerosis of the lower limb. Surgery 1973; 74: 637–40.

Levy P , Rush DS , Haynes JL . Lower extremity ischemia in patients less than 40 years old. J Vasc Surg 1992; 15: 250.

Evans WE , Hayes JP , Vermilion BD . Atherosclerosis in the younger patient. Results of surgical management. Am J Surg 1987; 154: 225–9.

Olsen PS , Gustafsen J , Rasmussen L , Lorentzen JE . Long-term results after arterial surgery for arteriosclerosis of the lower limbs in young adults. Eur J Vasc Surg 1988; 2: 15–18.

Valentine RJ , MacGillivray DC , DeNobile JW , Snyder DA , Rich NM . Intermittent claudication caused by atherosclerosis in patients aged forty years and younger. Surgery 1990; 107: 560–5.

Chancellor AM , Glasgow GL , Ockelford PA , Johns A , Smith J. Etiology, prognosis, and hemostatic function after cerebral infarction in young adults. Stroke 1989; 20: 477–82.

Bevan H , Sharma K , Bradley W. Stroke in young adults. Stroke 1990; 21: 382–6.

Hart RG , Miller VT . Cerebral infarction in young adults: a practical approach. Curr Concepts Cerebrovasc Dis 1982; 14: 111–14.

Castle DJ , Silber HM , Handler LC . Carotid artery disease in young adults. S Afr Med J 1991; 80: 278–81.

Ip JH , Fuster V , Badimon L , Badimon J , Taubman MB , Chesebro JH . Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15: 1667–87.

Fox B , James K , Morgan B , Seed A. Distribution of fatty and fibrous plaques in young human coronary arteries. Atherosclerosis 1982; 41: 337–47.

Velican D , Velican C. Atherosclerotic involvement of the coronary arteries of adolescents and young adults. Atherosclerosis 1980; 36: 449–60.

The Pathobiologic Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA 1990; 264: 3018–24.

Hallett JW , Greenwood LH , Robison JG . Lower extremity arterial disease in young adults. A systematic approach to early diagnosis. Ann Surg 1985; 202: 647–52.

Haimovici H. Patterns of arteriosclerotic lesions of the lower extremity. Arch Surg 1967; 95: 918–33.

Boyd AM . The natural course of arteriosclerosis of the lower extremities. Angiology 1960; 11: 10–14.

Hertzer NR , Beven EG , Young JR Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of management. Ann Surg 1984; 199: 223–33.

Valentine RJ , Grayburn PA , Timpa V Coronary artery disease is highly prevalent in patients with premature peripheral atherosclerosis. Circulation 1992; 86 (Suppl I): 1–305.

Barnes RW , Marszalek PB . Asymptomatic carotid disease in the cardiovascular surgical patient: is prophylactic endarterectomy necessary? Stroke 1981; 12: 497–500.

Hertzer NR . The natural history of peripheral vascular disease. Implications for its management. Circulation 1991; 83: (Suppl I: I-12–I-19.

Enos WF , Holmes RH , Beyer J. Coronary disease among United States soldiers killed in action in Korea. JAMA 1953; 152: 1090–3.

McNamara JJ , Molot MA , Stremple JF , Cutting RT . Coronary artery disease in combat casualties in Vietnam. JAMA 1971; 216: 1185–7.

Stary HC . Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arterosclerosis 1989; 99 (Suppl I): I-19–I-32.

Stary HC . Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children. Atherosclerosis 1987; 64: 91–108.

Klag MJ , Ford DE , Mead LA Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 1993; 328: 313–18.

Aronson DC , Ruys Th , van Bockel JH A prospective survey of risk factors in young adults with arterial occlusive disease. Eur J Vasc Surg 1989; 3: 227–32.

Manilow MR , Kang SS , Taylor LM Jr Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989; 79: 1180–8.

Harris EJ Jr , Taylor LM Jr , Manilow MR The association between elevated plasma homocyts(e)ine and symptomatic peripheral arterial disease. Surg Forum 1989; 40: 307–9.

Genest JJ , McNamara MR , Upson B Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease. J Am Coll Cardiol 1990; 15: 185A.

Harker LA , Ross R , Schlicter SJ , Scott CR . Homocystineinduced atherosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976; 58: 731–41.

Boers HJ , Smals AGH , Trijbels FJM Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313: 709–15.

Coull BM , Malinow MR , Beamer N Elevated plasma homocyst(e)ine concentrations as a possible risk factor for stroke. Stroke 1990; 21: 572–6.

Mudd SH , Skovby F , Levy HL The natural history of homocystinuria due to cystathionine-B-synthase deficiency. Am J Hum Genet 1985; 37: 1–31.

Schafer AI . The hypercoagulable states. Ann Intern Med 1985; 102: 814–28

Donaldson MC , Weinberg DS , Belkin M. Screening for hypercoagulable states in vascular surgery practice: a preliminary study. J Vasc Surg 1990; 11: 825–31.

Shapiro ME , Rodvien R , Bauer KA , Salzman EW . Acute aortic thrombosis in antithrombin III deficiency. JAMA 1981; 245: 1759–61.

Balkuv-Ulutin S. Fibrinolytic system in atherosclerosis. Semin Thromb Hemost 1986; 12: 91–101.

Hamsten A , Norberg R , Bjorkholm M Antibodies to anticardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet 1986; i: 113–16.

Eldrup-Jorgensen J , Flanigan P , Brace L Hypercoagulable states and lower limb ischemia in young adults. J Vasc Surg 1989; 9: 334–41.

Eason JD , Mills JL , Beckett WC . Hypercoagulable states in arterial thromboembolism. Surg Gynecol Obstet 1992; 174: 211–15.

Ahn SS , Kalunian K , Rosove M. Postoperative thrombotic complications in patients with the lupus anticoagulant: increased risk after vascular procedures. J Vasc Surg 1988; 7: 749–56.

Schneiderman J , Luskutoff DJ . Plasminogen activator inhibitors. Trends Cardiovasc Med 1991; 1: 99–101.

Gotto AM Jr , LaRosa JC , Hunninglake D The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. Circulation 1990; 81: 1721–33.

Rhoads GG , Dahlen G , Berg K Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256: 2540–4.

Kostner GM , Avogaro P , Cazzolato G Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981; 38: 51–61.

Zenker G , Koltringer P , Bone G Lipoprotein (a) as a strong indicator for cerebrovascular disease. Stroke 1986; 17: 942–5.

Jurgens G , Koltringer P. Lipoprotein (a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. Neurology 1987; 37: 513–15.

Murai A , Miyahara T , Fujimoto N Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986; 59: 199–204.

Hoff HF , Beck GJ , Skibinski CI Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988; 77: 1238–44.

Valentine RJ . Lipoprotein (a): a new risk factor for vascular disease. Perspect Vasc Surg 1992; 5: 84–99.

Dahlen GH , Guyton JR , Attar M Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758–65.

Armstrong VW , Cremer P , Eberle E The association between serum Lp(a) concentration and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 1986; 62: 249–57.

Koltringer P , Jurgens G. A dominant role of lipoprotein (a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis. Atherosclerosis 1985; 58: 187–98.

Molgaard J , Klausen C , Lassvik C Significant association between low-molecular-weight apoprotein (a) isoforms and intermittent claudication. Arteriosclerosis and Thrombosis 1992; 12: 895–901.

Kostner GM . The physiological role of Lp(a). In: Scanu AM , ed. Lipoprotein (a). San Diego, California: Academic Press, 1990: 183–204.